VERDOT®, established in 1950 and headquartered in Riom, France, stands at the forefront of downstream bioprocessing technology. VERDOT focuses on innovative purification solutions for the biopharmaceutical industry, including chromatography columns, and custom and standardized chromatography and tangential flow filtration (TFF) systems. VERDOT systems and columns are employed in the purification, separation and concentration of biomolecules such as monoclonal antibodies, vaccines, viral vectors (e.g., AAV and lentivirus), and mRNA-based therapeutics.
VERDOT serves a diverse customer base, including research and development, early-stage biotech, biopharma, and contract development and manufacturing organizations (CDMOs) in all stages of the drug development workflow from exploration through the manufacturing of commercially available biologics. VERDOT’s tailored, high-quality purification technologies empower their customers to accelerate time-to-market of groundbreaking and cost-effective therapies.
For more information about VERDOT, visit www.verdot-biotechnologies.com
-
Secteur
-
Recherche en biotechnologie
-
Taille de l’entreprise
-
51-200 employés
-
Siège social
-
Riom
-
Type
-
Société civile/Société commerciale/Autres types de sociétés
-
Fondée en
-
1950
-
Domaines
-
downstream biprocessing, custom-tailored systems, Chromatography Columns, Chromatography Systems, Tangential Flow Filtration (TFF), pilot-scale, commercial manufacturing , viral vector purificaiton, mRNA purificaiton, Recombinant protein purificaiton, mAb purificaiton, food and beverage bioprocessing, cell and gene therapy et vaccine purification
